In this study, we found that LNT upregulated the expression of PPARα and its target gene CPT1α, which is involved in lipid metabolism in the liver of NAFLD mice, as well as in AML12 cells in vitro. The gene discussed is CPT1A; the disease is metabolic dysfunction-associated steatotic liver disease.